Literature DB >> 3296763

Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus.

J S Pepose, S MacRae, T C Quinn, J W Ward.   

Abstract

Four corneas from two cadavers that later had positive test results on enzyme-linked immunosorbent assays and Western blot analysis for antibodies against the human immunodeficiency virus were inadvertently transplanted to recipients who were without known risk of human immunodeficiency virus infection. We performed serial studies of serologic markers of human immunodeficiency virus infection in the cornea recipients and assayed reverse transcriptase levels of their mixed lymphocyte cultures. The four cornea transplant recipients were followed up for 130, 152, 397, and 440 days, respectively, and the results on all serologic tests and reverse transcriptase assays remain negative.

Entities:  

Mesh:

Year:  1987        PMID: 3296763     DOI: 10.1016/s0002-9394(14)74396-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Corneal graft rejection in African Americans at Howard University Hospital.

Authors:  Larry Ferdinand; Vanessa Ngakeng; Robert A Copeland
Journal:  Saudi J Ophthalmol       Date:  2011-04-30

2.  Detection of HBs antigen, DNA polymerase activity, and hepatitis B virus DNA in tears: relevance to hepatitis B transmission by tears.

Authors:  P Gastaud; C Baudouin; D Ouzan
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

3.  Detection of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in donor eyes using polymerase chain reaction.

Authors:  J Shimazaki; K Tsubota; M Sawa; S Kinoshita; T Ohkura; M Honda
Journal:  Br J Ophthalmol       Date:  1994-11       Impact factor: 4.638

4.  Assessment of the infectivity of corneal buttons taken from hepatitis B surface antigen seropositive donors.

Authors:  A Khalil; M Ayoub; K S el-Din Abdel-Wahab; A el-Salakawy
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.